Drug Type Degradable Molecular Glue |
Synonyms- |
Target |
Action inhibitors |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | South Korea | 27 Apr 2025 | |
Colorectal Cancer | Preclinical | South Korea | 27 Apr 2025 | |
Non-Small Cell Lung Cancer | Preclinical | South Korea | 27 Apr 2025 | |
Non-Small Cell Lung Cancer | Preclinical | South Korea | 27 Apr 2025 | |
Pancreatic Ductal Adenocarcinoma | Preclinical | South Korea | 27 Apr 2025 | |
Pancreatic Ductal Adenocarcinoma | Preclinical | South Korea | 27 Apr 2025 |